Neurological Disorders and Psychometric Methods of Their Assessment in HIV Patients

Authors

  • N.R. Abdullayeva Ministry of Justice of the Republic of Azerbaijan, Penitentiary Institution No. 4, Medical and Preventive Department, Baku, Azerbaijan
  • А.K. Mammadbayli Azerbaijan Medical University, Department of Neurology, Baku, Azerbaijan
  • М.М. Mamedova Azerbaijan Medical University, Department of Neurology, Baku, Azerbaijan
  • R.N. Rzayev Azerbaijan Medical University, Department of Neurology, Baku, Azerbaijan
  • F.N. Маmmedbekov Azerbaijan Medical University, Department of Neurology, Baku, Azerbaijan
  • А.А. Musayeva Azerbaijan Medical University, Department of Neurology, Baku, Azerbaijan
  • S.P. Аlekberova Azerbaijan Medical University, Department of Neurology, Baku, Azerbaijan

DOI:

https://doi.org/10.61788/njn.v2i21.07

Keywords:

HIV, neurological disorders, neuropathy, cognitive impairment, scales

Abstract

This article presents the features of neurological disorders most common in HIV patients, as well as the assessment methods in evaluation of neurological problems using various scales for neurocognitive impairment and neuropathy in HIV patients.

References

Государственный статистический комитет Республики Азербайджан https://www.stat.gov.az

WHO World Health Organization https://www.who.int

Hellmuth J., Fletcher J.L., Valcour V., Kroon E. et al & SEARCH 010/RV254 Study Group. Neurologic signs and symptoms frequently manifest in acute HIV infection // Neurology, 2016, 87(2), 148-154. https://doi.org/10.1212/WNL.0000000000002837

Banerjee, N., McIntosh, R. C., & Ironson, G. (2019). Impaired Neurocognitive Performance and Mortality in HIV: Assessing the Prognostic Value of the HIV-Dementia Scale // AIDS and behavior, 23(12), 3482-3492. https://doi.org/10.1007/s10461-019-02423-w

Saylor D., Dickens A.M., Sacktor N., Haughey N. et al. HIV-associated neurocognitive disorder- -pathogenesis and prospects for treatment // Nature reviews. Neurology, 2016, 12(4), 234-248. https://doi.org/10.1038/nrneurol.2016.27

Nir T.M., Jahanshad N., Ching C., Cohen R.A. et al & HIV Neuroimaging Consortium. Progressive brain atrophy in chronically infected and treated HIV+ individuals // Journal of neurovirology, 2019, 25(3), 342-353. https://doi.org/10.1007/s13365-019-00723-4.

Angelovich, T.A., Churchill, M.J., Wright, E.J., Brew, B.J. New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment // Current topics in behavioral neurosciences, 2021, 50, 3-39. https://doi.org/10.1007/7854_2019_126

Кутлубаев M.A. Выявление когнитивного дефицита в практике терапевта: обзор скрининговых шкал // Терапевтический архив, 2014, 86 (11), 135-138.

Nasreddine Z.S., Phillips N.A., Bedirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment // J Am Geriatr Soc 2005; 53: 695-699.

Rosca E.C., Albarqouni L., Simu M. Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders // Neuropsychology review, 2019, 29(3), 313-327. https://doi.org/10.1007/s11065-019-09412-9.

Rocha M., Bassetti E.M., Oliveira M.O., Kuark R., Estevam N.M., Brucki S. Addenbrooke's Cognitive Examination-Revised is accurate for detecting dementia in Parkinson's disease patients with low educational level // Dementia & neuropsychologia, 2014, 8(1), 20-25. https://doi.org/10.1590/S1980-57642014DN81000004

Болотов А. В. Скрининговые шкалы для оценки когнитивных расстройств при хронической цереброваскулярной патологии // Лечебное дело, 2009, (3), 81-84.

Skinner S., Adewale A.J., DeBlock L., Gill M.J., Power C. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy // HIV medicine, 2009, 10(4), 246-252. https://doi.org/10.1111/j.1468-1293.2008.00679.x.

Gabbai A.A., Castelo A., Oliveira A.S. HIV peripheral neuropathy // Handbook of clinical neurology, 2013, 115, 515-529. https://doi.org/10.1016/B978-0-444-52902-2.00029-1

Gawde A.K., Emmady P.D. HIV-1 Associated Progressive Polyradiculopathy. In StatPearls. StatPearls Publishing. 2021.

Egan K.E., Caldwell G.M., Eckmann M.S. HIV Neuropathy-a Review of Mechanisms, Diagnosis, and Treatment of Pain // Current pain and headache reports, 2021, 25(8), 55. https://doi.org/10.1007/s11916-021-00971-2

Simpson D.M., Rice A.S., Emir B., Landen J., Semel D., Chew M.L., Sporn, J. A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy // Pain, 2014, 155(10), 1943-1954. https://doi.org/10.1016/j.pain.2014.05.027

Scott W., Guildford B.J., Badenoch J., Driscoll E. et al. Feasibility randomized-controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN study // European journal of pain (London, England), 2021, 25(7), 1493-1507. https://doi.org/10.1002/ejp.1762

Amaniti A., Sardeli C., Fyntanidou V., Papakonstantinou P. et al. Pharmacologic and Non-Pharmacologic Interventions for HIV-Neuropathy Pain. A Systematic Review and a Meta-Analysis // Medicina (Kaunas, Lithuania), 2019, 55(12), 762. https://doi.org/10.3390/medicina 55120762

Woldeamanuel Y.W., Kamerman P.R., Veliotes D.G., Phillips T.J. et al. Development, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study Settings // PloS one, 2016, 11(10), e0164994. https://doi.org/10.1371/journal.pone.0164994.

Evans M.C., Wade C., Hohenschurz-Schmidt D., Lally P. et al. Magnetic Resonance Imaging as a Biomarker in Diabetic and HIV-Associated Peripheral Neuropathy: A Systematic Review-Based Narrative // Frontiers in neuroscience, 2021, 15, 727311. https://doi.org/10.3389/fnins. 2021.727311.

Julian T., Rekatsina M., Shafique F., Zis P. Human immunodeficiency virus-related peripheral neuropathy: A systematic review and meta-analysis // European journal of neurology, 2021, 28(4), 1420-1431. https://doi.org/10.1111/ene.14656.

Bril V., Tomioka S., Buchanan R.A., Perkins B.A., & mTCNS Study Group. Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy // Diabetic medicine: a journal of the British Diabetic Association, 2009, 26(3), 240-246. https://doi.org/10.1111/j.1464-5491.2009.02667.x.

May S., Serpell M. Diagnosis and assessment of neuropathic pain //F1000 medicine reports, 2009, 1, 76. https://doi.org/10.3410/M1-76.

Downloads

Published

31.12.2021

How to Cite

Abdullayeva, N., Mammadbayli А., Mamedova М., Rzayev, R., Маmmedbekov F., Musayeva А., & Аlekberova S. (2021). Neurological Disorders and Psychometric Methods of Their Assessment in HIV Patients. National Journal of Neurology, 42–48. https://doi.org/10.61788/njn.v2i21.07

Issue

2021: No.2 (20)

Section

Help to the Practical Doctor

License

Copyright (c) 2026 National Association of Neurologists

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.